Member Info for JustHereForHemo

I thought Pingu is off playing with the chickens so was preparing a reply but I see he has replied anyway :P Anyway I strongly believe we will be north of £1 in a year. I am going to qualify that with some very basic numbers so you dont think I am full of sh..t..

£1 Per share at 434 Million shares gives Hemogenyx an MCap of ... well £434Mil currently sitting at an MCap of £39Mil
So to justify that £434 Mil we have to assess which if any of Hemogenyx products currently in development would warrant that.

1, CDX BiSpecific Antibodies targeting AML - This is believed to be about to go into Clinical Stage 1 trials with Eli Lilly assuming they take Hemo up on the Licencing agreement. It is hard to assess what exactly the up front payment will be but have a look at https://hemogenyx.com/broker-coverage/ and you will see the numbers, it could go from low 10's of millions up to 100's of mil. There would then be further milestone payments and royalties when it goes to market provided it passes all trials. Stand alone I dont believe CDX will be enough for £434M MCap within 1 year but a sizeable chunk of it.

2, Todays announcement, CAR-T Agreement with University of Pennsylvania targeting AML working with the June Laboratory... You can do some quick googling but the last product they brought to market helping ALL sufferers has been shown to be cost effective and yet still costs north of 400k per patient for one treatment! AML is somewhat similar with a massive potential market. And as of now its 100% Hemogenyx which to me justifys a valuation of £434m once its though atleast Phase II trials

3, Orgenesis - Lets not forget that they are working away using Hemogenxy mice, they have launched a BioDefense platform, who knows what it will generate in revenue but you are talking defence contracts and Hemo are in line for 12% revenue, guess 10's of Mil?

4, Covid 19 Prognostic test or antibodies.... There has been complete radio silence on this recently, we have seen what Covid developments have done to SP. There is no competition for the test under development and as for the Antibodies? the market is too big to fill, IF Hemo can produce they will sell. Have to wait and see for this one, potentially 100's of Mil, or nothing.

5, Take over - Forget £1, too many products in the pipeline, I realistically cannot see a take over as any less than $1bn so your talking more than $2 per share.

6, Super mice, Mils -> 10s of Mil -> 100s of mils depends on customer

7, Hu-PHEC... etc etc

Basically there are so many potential revenue streams, any one could potentially be a £1 share price earner, its all a question of timing. It has been years in the making but 2020 and 2021 are the culmination of that work, Expect CDX and HEMO-CAR-T in Stage 1 clinical trials within months, then the SP will truly rocket.

Well said Gareth, there might be some fall back, potentially, like worst case MAYBE 8p???very greatly doubt it but its possible I guess. So someone has the potential to pay a penny more than they might get in at. Meanwhile every single day they risk the CDX agreement and multiple bags.
I just don't get the risk reward calculation people are doing, chasing the 5-10% savings or profits at the risk of 3-500%
If people don't think hemo will be 20,30,50,80,100,180p etc why on earth are they investing?
And if they believe hemo will do those sorts of numbers why are they playing around with an entry point that according to their target is a bargain?

Go back and look what happened 21st and 22nd April. Vlad does not artifically spread news out, when its ready he releases. CDX / Covid news could easily come tomorrow or this week. We have had several good blue days, today continued the blue trend. Hemogenyx is getting noticed in the world for its potential in Oncology. More and more high powered agreements and contacts. Its certainly not a one trick pony, its not a fad or a fake. THE BEST scientists and brains in the world are starting to work with Hemogenyx.... IMO we wont drop very far if atall, if I am wrong call me on it, I just think we are getting too much attention and there is too much potential and FOMO is bringing in more investment than we have leaving for the 5/10% takers.
Have a good evening

@Findme if you read some of the old RNS you can get contact details for the likes of PeterHouse or SP Angel or contact details for some of the BoD and you can ask them how they feel about the SP. Its no big secret, Vlad and the BoD want to deliver for share holders. Its not sensitive inside information that they want to build new "Higher Lows" and has been said before on Twitter I am sure that Hemogenyx want to build the SP for share holders. The Research notes have shown just how under valued it is.
We are coming close to news about Licencing agreement being signed with Eli Lilly, whatever the SP is on the day that RNS is released will matter. Many people will sell at a certain percentage no matter what the RNS says, if we are sitting at 9p and news drops people will sell at 18p, 100% profit and they will be ecstatic, eventually enough will sell and we run out of steam. If we start at say 15p then people will hold to 30p...
People can say all they want that it doesn't matter what the SP is now, when news lands it will blow, yes it will blow but the higher we are BEFORE news lands the higher it will go AFTER news lands.

Also why on earth did you decide to have a dig at Asleep? It was a very unremarkable and frank post. You could say the same about ANY CEO for any company on the stock exchange its common sense...

Buyers in america can buy shares on the LSE using a broker who deals with the LSE just like I can buy shares on the NYSE WHEN its open in USA, Americans can buy shares here from 8am GMT just like the rest of us.
They are just more likely to be sleeping when our markets open...
US time does have have an impact on RNS announcements for Hemo, news may be tied to say Eli Lilly so makes sense to release 2-3pm as we have seen in the past.
For big news like signing a contract the RNS could come very soon after the actual event so it could be like 3pm some day.

:-) Amazing holding Let-It-Roll, less than 2.5m for me, currently somewhere around £70k in profit.

You are spot on, this is a golden egg moment, in terms of time scales, budgets etc I have a feeling the tweet was definitely more of a wink wink situation than any sort of warning. I thought the HEMO-CAR-T tie up would be months away, well after the Covid and CDX work was off their hands, but no it appears to be high priority!
Look at who he has chosen to work with??!?? Its such a perfect fit! They are basically working with matter experts who know exactly the field they are targeting, in terms of speed, knowledge RE FDA regulations, getting to trials and then to market??

You literally cannot buy this experience that they are getting.

Dr. Saar Gill, Assistant Professor of Medicine, a hematologist-oncologist physician scientist and Scientific co-Director of the Cell Therapy and Transplantation program at Penn, will serve as Principal Investigator.

The CAR T-cells invented in the June Laboratory were awarded "Breakthrough Therapy" status by the FDA.. culminating with the FDA approval of the first CAR T-cell therapy Kymriah ® (tisagenlecleucel) for the treatment of ALL in 2017.

https://pubmed.ncbi.nlm.nih.gov/30212291/

With a one-time infusion cost of $475,000, tisagenlecleucel is currently the most expensive oncologic therapy. We aimed to determine whether tisagenlecleucel is cost effective compared with currently available treatments.

Hemogenyx MCap is currently ~£40M..... And the market they are playing in produces treatments that can fetch up to $475k PER treatment...

Good luck with your £300.
If we had alot more investors holding shares instead of just day traders then it would have been alot more than £300 for you but like I said earlier: "Have fun trading and playing around at these levels"
A churn of shareholders is good, we had what 150k paid for shares at 10 within the first few minutes of opening? Those share holders are much less likely to sell for < 10p
We will reach a point where the slippery fingers will let go and wont get back in, until then fill your boots as they say, I could make a few thousand doing the same but I could not do it with my entire holding and any small profits I make with say 200k shares would just harm the overall value of my portfolio so no, its not for me. Every 0.1p that we rise makes me £2.5k so its in my interest not to cause a fall in SP.
Anyway @Findme, never seen you before, dont know you, wish you no ill will, good luck with your share dealing, we have 2 completely different approaches but Hemogenyx will make us both a decent profit.

https://twitter.com/NiSpeach/status/1293097784808214528?s=20
The shake down to low 9s was absolutly necessary by the MMs this morning, they got cleaned out at 10p,
The number of 100k trades on the bell at 8am paying 10p+ shows you that the smart money wants in and wants in NOW
If your selling below 9p, good luck where ever you go next, I suspect Hemogenyx is not for you!

Amazing to see such volume of trades and its not even 9am!
Not exactly sure why anyone would sell when shares are in such demand but hey ho! Work away, plenty waiting to snap them up. This news was expected but not high on list of priorities, in terms of coming so soon, personally I thought they would be too busy to partner up but looks like they are more advanced than thought!!!

We are confident that this collaboration will dramatically accelerate the development of our CAR-T product candidate, which we believe will have a significant and positive impact in the treatment of acute myeloid leukemia, for which there is currently no real effective treatment."

If they accelerate and get this into Phase 1 Clinical trials!!?? Pharma will be knocking down the door to buy out the product early. IF they can withstand the deluge of offers and take it through clinical trials with just UoP???? Forget it, we are talking phone numbers...

Anyhoo, dont miss the big picture, still expecting the Eli Lilly licencing agreement and update on Covid test, atleast one of which I expect to hit within the next week.

Have fun trading and playing around at these levels, they dont interest me in the slightest, I am sure some will make profits buying and selling at these low values, I wont be one of them, for me Eli news is too imminent so its not worth the risk personally but I wont judge others for thinking differently!

Good luck on the wagon and garth and with eua, hopefully lots of profits for you there as well as hemo :-)

Sells are showing as a sell.
Buys are showing as a sell.
MMs have sold more Shares than they have bought in the past few hours they need to restock so that they can sell again.
Therefore they drop the price, change the Bid and Ask to make it look like all trades are sells.
People see trades, assume everyone is selling, start panicing that the rise was too good to be true, decide to sell perhaps in profit perhaps not.
MMs once they have enough shares to sell again, start making buys look like buys.
People see trades, assume everyone is buying, panic that everyone knows something that they dont, hit buy buy buy!!!
And so goes the circle of life! :-)
Some people play this loop and make small but consistent profits, I am lazy, I will pass up on the <5 % profits as a day or two to wait for news is nothing considering how long I have already waited, but just wanted to try and clarify the movements a little!
As for the 1 code trades or 911 trades, IMO pure BS the MMS dont know about early news, even if they did they would not use a trade to broadcast it to everyone!!!! They DO however place small trades to each other like 100 shares at the exact bid or ask to say to other MMS "Hey mates, I really need shares to fill a big order, mind stepping aside and letting me drop the price so I can fill my order?"

They look like they are playing fair!!
Market seems to be shifting the price fairly based on buys and sells, you RARELY see this with Hemogenyx, normally MMs forcing the prices down. Perhaps there is too much pressure from the PIs and they cannot maintain downward pressure, either way its fantastic to see. Looks like the unicorn chasers are buying back in before news drops, I am somewhat annoyed that it has worked for you all, but at the same time welcome back, I hope we all do very well in the coming days and weeks.
Brokers note alluded to a valuation of around 77p per share I believe? Others may be able to read it and understand better, either way, double figures probably not too far away now, still see the odd trader taking their 5-10%, if there is no fall back that will be the end of them, then its upwards and onwards :-)

#InVladWeTrust

Hemogenyx has been massively under priced for along time, news is absolutly due and we are expecting updates on many fronts not least Covid-19 and CDX with Eli Lilly. I have not heard of any LEAKS exactly but we know the news is due any time, we also know lots of investors including some previously long term holders decided to sell a while ago to go chase unicorns hoping to return before the news drops.
Unfortunately it does not work like that, when lots of people want back on the boat and the boat is full you have to pay a premium for your ticket. MIGHT be news today, Personally I dont think so, feel its days away, but FOMO is definitely kicking in and everyone wants their shares back, well sorry folks, you gotta pay!

I'm not surprised. Just disappointed.

Wouldn't want to be out over the weekend :-D

??

If you listen to anyone who decides to pick a screen name after that orange Dotard then you deserve to lose money.

I wouldn't worry about the likes of Pumpkin returning, Hemo does not work for her anymore. There used to be enough gullable new holders who would panic and sell or panic and buy and there was day after day where the sp swung up and down +-10% most shares now in confident sticky hands so not much volume. As a result the MMs have ZERO intention of paying for the likes of Pumpkin to take their wee 5-10% profits at their expense. While the spread is this big we hopefully won't be putting up with her passive aggressive manuplitive de-ramping running commentary on her bs trading activities.